RT Journal Article
SR Electronic
T1 A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.26.20044826
DO 10.1101/2020.03.26.20044826
A1 Zhu, Yanshan
A1 Bloxham, Conor J.
A1 Hulme, Katina D.
A1 Sinclair, Jane E.
A1 Marcus Tong, Zhen Wei
A1 Steele, Lauren E.
A1 Noye, Ellesandra C.
A1 Lu, Jiahai
A1 Xia, Yao
A1 Chew, Keng Yih
A1 Pickering, Janessa
A1 Gilks, Charles
A1 Bowen, Asha C.
A1 Short, Kirsty R
YR 2020
UL http://medrxiv.org/content/early/2020/12/04/2020.03.26.20044826.abstract
AB The role of children in the spread of SARS-CoV-2 remains highly controversial. To address this issue, we performed a meta-analysis of the published literature on household SARS-CoV-2 transmission clusters (n=213 from 12 countries). Only 8 (3.8%) transmission clusters were identified as having a paediatric index case. Asymptomatic index cases were associated with a lower secondary attack in contacts than symptomatic index cases (estimate risk ratio [RR], 0.17; 95% confidence interval [CI], 0.09-0.29). To determine the susceptibility of children to household infections the secondary attack rate (SAR) in paediatric household contacts was assessed. The secondary attack rate in paediatric household contacts was lower than in adult household contacts (RR, 0.62; 95% CI, 0.42-0.91). These data have important implications for the ongoing management of the COVID-19 pandemic, including potential vaccine prioritization strategies.40-word summary In household transmission clusters of SARS-CoV-2 children are unlikely to be the index case. Children are also less likely than adults to be infected with SARS-CoV-2 from a family member.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKRS was supported by the Australian Research Council [DE180100512]. ACB receives funding from the National Health and Medical Research Council with an Investigator Award (1175509).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors have full access to all the data in the study.